Fareva to Acquire/Expand Pfizer Facility in VA and Add 90 New Jobs
09/01/2011
The two companies now have a manufacturing and supply agreement enabling the facility to continue production of Pfizer consumer products for global customers. All of the nearly 500 Pfizer workers employed at the site will transfer to Fareva, and 90 new jobs will be created.
Fareva will continue to operate the facility, which manufactures and packages brand-name products such as Chapstick, Advil and Robitussin. Headquartered in Luxembourg, the company employs 5,500 associates and operates 28 manufacturing facilities in Europe and emerging markets. It reported $1.2 billion in 2010 revenues.
The company CEO Bernard Fraisse said Fareva has been looking for the right opportunity to expand its manufacturing footprint into North America, and establish its pharmaceutical and cosmetics businesses in the U.S. "The Henrico County site has a talented and motivated workforce and state-of-the-art manufacturing, packaging and warehousing facilities that are a perfect fit for growing our commercial portfolio in this region."
Governor McDonnell approved a $650,000 grant from the Governor's Opportunity Fund to help Henrico County with the project, and approved an $800,000 performance-based grant from the Virginia Investment Partnership program. Moreover, the Virginia Jobs Investment Program will provide funding and services to support the company's recruitment, training and retraining activities.
Project Announcements
Becton, Dickinson and Company Expands Columbus, Nebraska, Operations
02/15/2026
Umbra Plans Reston, Virginia, Operations
02/15/2026
Davie Defense Expands Galveston-Port Arthur, Texas, Operations
02/15/2026
Swiss-Based Georg Utz Plana Sumter, South Carolina, Packaging Operations
02/15/2026
Coastal Precast Systems Plans Clinton, South Carolina, Operations
02/15/2026
Taiwan-Based PharmaEssentia Plans Puerto Rico, Manufacturing Operations
02/14/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026